Multicenter, Open-Label, Phase I Study of DSP-7888 Dosing Emulsion in Patients with Advanced Malignancies

BACKGROUND: Wilms’ tumor 1 (WT1) is overexpressed in various malignancies. DSP-7888 Dosing Emulsion, also known as ombipepimut-S (United States Adopted Name; International Nonproprietary Name: adegramotide/nelatimotide), is an investigational therapeutic cancer vaccine comprising two synthetic pepti...

Descripción completa

Detalles Bibliográficos
Autores principales: Spira, Alexander, Hansen, Aaron R., Harb, Wael A., Curtis, Kelly K., Koga-Yamakawa, Erina, Origuchi, Makoto, Li, Zhonggai, Ertik, Bella, Shaib, Walid L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8266707/
https://www.ncbi.nlm.nih.gov/pubmed/33939067
http://dx.doi.org/10.1007/s11523-021-00813-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8266707/
https://www.ncbi.nlm.nih.gov/pubmed/33939067
http://dx.doi.org/10.1007/s11523-021-00813-6

Ejemplares similares